Biotech grants in France

Funds companies scaling up sustainable macroalgae cultivation and turning the harvest into new bio-based food, feed or industrial products.

Funds late-stage clinical trials of treatments and diagnostics for six climate-linked diarrhoeal disease pathogens in sub-Saharan Africa.

Closed

Funds clinical and pre-clinical research that pins down the causes of, and builds better diagnostics and treatments for, medical conditions that are common but poorly understood, such as ME/CFS, autism, gynaecological diseases and low back pain.

Closed

Co-funds Polish translational cancer-metabolism research done with an international team.

Funds beyond-proof-of-concept innovations that make infectious-disease prevention, treatment or diagnostics cheaper, more accessible or better suited to sub-Saharan Africa.

Closed

Pays biomedical New Approach Methodology developers a fixed EUR 300,000 lump-sum grant to validate animal-free testing methods and prepare them for regulatory use.

Funds one project mining research cohorts and biobanks to find causal links between infections and non-communicable diseases, aimed at new vaccines, diagnostics and early treatments.

Closed

Funds research into how environmental exposures interact with genetic and lifestyle factors to cause cancer in children, adolescents and young adults.

Closed

Funds AI and digital-twin tools that speed up bio-based manufacturing — from biorefinery process control to predicting biosynthesis pathways.

Funds a full-scale flagship biorefinery that turns separately-collected urban bio-waste into higher-value bio-based products instead of compost or biomethane.

Closed

Funds the advancement of existing vaccine candidates against one named epidemic-prone virus, from lab testing through to a first human safety trial.

Funds research into new tools and conversion routes that turn low-value forest residues into bio-based chemicals, materials or products beyond bioenergy.

Open

Funds JCJC laureates and their teams preparing strong proposals to advance high-impact scientific careers.

Open

Funds SMEs maturing and testing technology projects with grants of up to EUR 50,000.

Open

Funds French companies carrying out high-growth R&D projects with regional grants or recoverable advances.

Open

Funds French and German collaborative companies with bilateral support for joint innovation projects.

Open

Funds overseas French SMEs industrialising or commercialising completed innovation projects with grants of EUR 20,000 to EUR 100,000.

Open

Supports French early-growth companies with a favourable tax and social relief status during early innovation growth.

Between cycles

Funds French SMEs and mid-sized companies pursuing high-uncertainty innovation with a recoverable advance.

Between cycles

Funds French small and medium enterprises focused on innovative prototyping, technology development, and pilot commercialization.

Between cycles

Offers French companies tax support that lowers the cost of qualifying innovation activity.

Closed

Funds French organizations through ANR's broad flagship call in multiple priority research themes.

Closed

Funds one organisation to run youth-led community and entrepreneurship actions across the EU's Outermost Regions.

Open

Supports Alzheimer’s and dementia drug development from preclinical readiness to early clinical testing across diverse modalities.